Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Evaluation of antidiabetic activities of Etlingera elatior flower aqueous extract in vitro and in vivo

Nor Asiah Muhamad Nor,Liza Noordin,Nor Hidayah Abu Bakar,Wan Amir Nizam Wan Ahmad .




Abstract
Cited by 19 Articles

Diabetes mellitus (DM) is a global health problem for millions of people worldwide. Nowadays, medicinal plants have started gaining more attention to diabetes management due to minimal side effects and cost-effectiveness. This study aims to ascertain the antidiabetic potential of Etlingera elatior flowers aqueous extract (EEAE) on in vitro inhibition of carbohydrate digestive enzymes and in vivo type 2 DM rat model. Findings demonstrated that E. elatior flower has a high percentage of inhibitory activity against α-amylase (99.70 ± 2.88%) and moderate activity for the α-glucosidase enzyme (52.39 ± 1.50%). Besides, E. elatior flower also has exhibited an antihyperglycaemic effect that is dose-dependent and has significantly decreased the elevated total cholesterol, triglycerides, and LDL levels in the in vivo study. Furthermore, serum creatinine, AST, and ALP also have significantly decreased when compared to untreated DM. The high content of total phenolic (39.06 ± 1.59 mg GAE/g), total flavonoid (39.00 ± 2.42 mg GAE/g extract), and potent antioxidant activity was suggested to contribute in the antidiabetic activity of the extract. In conclusion, E. elatior flower potentially could be developed as a natural source of antioxidants that can be used for the prevention or treatment of diabetes.

Keywords: Etlingera elatior, antidiabetic activity, in vitro, in vivo.

Key words: Etlingera elatior, antidiabetic activity, in vitro, in vivo.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.